OpenAlex
PricingAboutJobs
Log inGet started
Work

Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation

HTML

Year: 2015
Type: article
Source: Nature
DOI: 10.1038/nature14119
Authors: Tea Pemovska, Eric Johnson, Mika Kontro, Gretchen A. Repasky, Jeffrey Chen, Peter Wells, Ciarán N. Cronin, Michele McTigue, Olli Kallioniemi, Kimmo Porkka, Brion W. Murray, Krister Wennerberg
Institutions: University of Helsinki, Institute for Molecular Medicine Finland, Pfizer (United States), Helsinki University Hospital
Language: English

Topic: Chronic Myeloid Leukemia Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: axitinib, BCR-ABL1, T315I mutation, chronic myeloid leukemia, acute lymphoblastic leukemia, drug repurposing, VEGFR inhibitors, kinase inhibitor resistance, gatekeeper mutation, patient-derived primary cells, ex vivo drug testing, imatinib resistance, multikinase inhibitor
SDG: Good health and well-being

Open Access status: closed

Funders: Università degli Studi di Milano-Bicocca, Jane ja Aatos Erkon Säätiö, Turun Yliopisto
OpenAlex ID: W2034351069
FWCI: 24.72
Cites: 40
Cited by: 255
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms